PTAFR and neoplasm: Notably, clinical studies demonstrated that high tumoral-PAFR expression correlates with increasing tumor stages/invasiveness, poor prognosis, and decreased overall survival in lung and esophageal squamous cell carcinoma patients [12, 13].